INTERNATIONAL PATENT: R-PHARM OVERSEAS, INC. FILES APPLICATION FOR "USE OF THE IL-6 INHIBITOR OLOKIZUMAB FOR THE TREATMENT OF PROGRESSIVE FIBROTIC INTERSTITIAL LUNG DISEASES"

GENEVA, Aug. 13 -- R-PHARM OVERSEAS, INC. (505 Coast Blvd. So., Suite 102La Jolla, CA 92037) filed a patent application (PCT/US2025/014126) for "USE OF THE IL-6 INHIBITOR OLOKIZUMAB FOR THE TREATMENT OF PROGRESSIVE FIBROTIC INTERSTITIAL LUNG DISEASES" on Jan 31, 2025. With publication no. WO/2025/166232, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MASLYANSKY, Alexey (189 Moskovsky Prospect, Apt. 64St.Petersburg, 196066), ZOTKINA, Kira (20 Orbeli St. Apt. 36St.Petersburg, 194223), SAMSONOV, Mikhail (74-6-77 Leningradsk...